Tetrahydrocannabivarin (THCV) Research Dashboard
Studies by Organ System
No data to display
Studies by Country of Researcher
No data to display
Top Conditions Related to THCV Studies
No data to display
Receptors Associated with THCV Studies
No data to display
THCV Has Shown Proven Effects in Clinical Human Trials for these conditions:
Page Quick Links
Select New Cannabinoid
8 PRIMARY STUDIES | 18 TOTAL STUDIES
Beneficial effects of the phytocannabinoid Δ 9-THCV in L-DOPA-induced dyskinesia in Parkinson's disease
Antioxidant and antimicrobial activity of two standardized extracts from a new Chinese accession of non-psychotropic Cannabis sativa L
Potential of Cannabinoid Receptor Ligands as Treatment for Substance Use Disorders
Δ8 -Tetrahydrocannabivarin has potent anti-nicotine effects in several rodent models of nicotine dependence
Efficacy and Safety of Cannabidiol and Tetrahydrocannabivarin on Glycemic and Lipid Parameters in Patients With Type 2 Diabetes: A Randomized, Double-Blind, Placebo-Controlled, Parallel Group Pilot Study.
Neural effects of cannabinoid CB1 neutral antagonist tetrahydrocannabivarin on food reward and aversion in healthy volunteers
The cannabinoid Δ9-tetrahydrocannabivarin (THCV) ameliorates insulin sensitivity in two mouse models of obesity.
Δ8-Tetrahydrocannabivarin Prevents Hepatic Ischaemia/Reperfusion Injury by Decreasing Oxidative Stress and Inflammatory Responses Through Cannabinoid CB2 Receptors
10 RELATED STUDIES | 18 TOTAL STUDIES
Cannabis compounds exhibit anti-inflammatory activity in vitro in COVID-19-related inflammation in lung epithelial cells and pro-inflammatory activity in macrophages
In vitro and in vivo pharmacological activity of minor cannabinoids isolated from Cannabis sativa
Cannabinoid Signaling in the Skin: Therapeutic Potential of the “C(ut)annabinoid” System
Future Aspects for Cannabinoids in Breast Cancer Therapy
Simultaneous Quantification of 13 Cannabinoids and Metabolites in Human Plasma by Liquid Chromatography Tandem Mass Spectrometry in Adult Epilepsy Patients
Potential Mechanisms Influencing the Inverse Relationship Between Cannabis and Nonalcoholic Fatty Liver Disease: A Commentary
Lifestyle and Metabolic Syndrome: Contribution of the Endocannabinoidome
Molecular Targets of the Phytocannabinoids-A Complex Picture
Non-THC Cannabinoids Inhibit Prostate Carcinoma Growth In Vitro And In Vivo: Pro-apoptotic Effects And Underlying Mechanisms
Plasma and brain pharmacokinetic profile of cannabidiol (CBD), cannabidivarine (CBDV), Δ⁹-tetrahydrocannabivarin (THCV) and cannabigerol (CBG) in rats and mice following oral and intraperitoneal administration and CBD action on obsessive-compulsive behaviour.
Overview - Tetrahydrocannabivarin (THCV)
Description of Tetrahydrocannabivarin (THCV)
Δ9-Tetrahydrocannabivarin (THCV) was discovered in 1971. It belongs to the THC group but produces different effects than THC. A lot of attention is given THCV of late due to the observation that it may be able to produce therapeutic effects in obesity related diabetes especially in contrast to the failed approach with Rimonabant, the CB1 inverse agonist used to treat obesity but then pulled from market due to the potential increased of mood disorders.Other Names:
Delta 9-Trans-TetrahydrocannabivarinTetrahydrocannabivarin (THCV) Properties and Effects
Affects lipid and sugar metabolism, Antipsychotic effectsTetrahydrocannabivarin (THCV) Receptor Binding
Recent reports suggest THCV is a tissue specific or dose-dependent (high dose) agonist/(low does) antagonist at CB1 receptors. Recent reports suggest THCV is a tissue specific or dose-dependent (high dose) agonist/(low does) antagonist at CB2 receptors. GPR-55 receptors. TRPV receptors. Serotonin receptors (5-HT1A)Disclaimers: Information on this site is provided for informational purposes only and is not meant to substitute for the advice provided by your own physician or other medical professional. You should not use the information contained herein for diagnosing a health problem or disease. If using a product, you should read carefully all product packaging. If you have or suspect that you have a medical problem, promptly contact your health care provider.
Information on this site is based on scientific studies (human, animal, or in vitro), clinical experience, or traditional usage as cited in each article. The results reported may not necessarily occur in all individuals. For many of the conditions discussed, treatment with prescription or over-the-counter medication is also available. Consult your physician, nutritionally oriented health care practitioner, and/or pharmacist for any health problem and before using any supplements or before making any changes in prescribed medications.